azacitidine and Erythroderma, Sezary

azacitidine has been researched along with Erythroderma, Sezary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caligiuri, MA; Frederickson, J; Geyer, S; Gibson, H; Hake, T; Marcucci, G; Mishra, A; Porcu, P; Wong, HK	1
Cheng, PF; Dummer, R; Fujii, K; Levesque, MP; Rozati, S; Widmer, DS	1

Other Studies

2 other study(ies) available for azacitidine and Erythroderma, Sezary

Article	Year
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome. The Journal of investigative dermatology, 2015, Volume: 135, Issue:8 Topics: Aged; Azacitidine; Case-Control Studies; Cell Line; DNA Methylation; Female; Fibroblasts; GATA6 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Jurkat Cells; Lymphocytes; Male; Membrane Glycoproteins; Microfilament Proteins; Middle Aged; Nuclear Proteins; Promoter Regions, Genetic; RNA, Messenger; Sezary Syndrome; Skin Neoplasms; Twist-Related Protein 1; Up-Regulation	2015
Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Apr-15, Volume: 22, Issue:8 Topics: Acetylation; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cluster Analysis; CpG Islands; Depsipeptides; DNA Methylation; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Promoter Regions, Genetic; Protein Binding; Sezary Syndrome	2016

Article

Year

Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.

The Journal of investigative dermatology, 2015, Volume: 135, Issue:8

Topics: Aged; Azacitidine; Case-Control Studies; Cell Line; DNA Methylation; Female; Fibroblasts; GATA6 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Jurkat Cells; Lymphocytes; Male; Membrane Glycoproteins; Microfilament Proteins; Middle Aged; Nuclear Proteins; Promoter Regions, Genetic; RNA, Messenger; Sezary Syndrome; Skin Neoplasms; Twist-Related Protein 1; Up-Regulation

2015

Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Apr-15, Volume: 22, Issue:8

Topics: Acetylation; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Cluster Analysis; CpG Islands; Depsipeptides; DNA Methylation; Dose-Response Relationship, Drug; Drug Synergism; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Promoter Regions, Genetic; Protein Binding; Sezary Syndrome

2016